Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order
- PMID: 22016903
Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order
Abstract
The Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three synthetic cathinones under the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 4-methyl-N-methylcathinone (mephedrone), 3,4-methylenedioxy-N-methylcathinone (methylone), and 3,4-methylenedioxypyrovalerone (MDPV). This action is based on a finding by the Administrator that the placement of these synthetic cathinones and their salts, isomers, and salts of isomers into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the full effect of the CSA and its implementing regulations including criminal, civil and administrative penalties, sanctions and regulatory controls of Schedule I substances will be imposed on the manufacture, distribution, possession, importation, and exportation of these synthetic cathinones.
Similar articles
-
Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order.Fed Regist. 2012 Oct 18;77(202):64032-3. Fed Regist. 2012. PMID: 23077760
-
Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.Fed Regist. 2014 Mar 7;79(45):12938-43. Fed Regist. 2014. PMID: 24611212
-
Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.Fed Regist. 2013 May 16;78(95):28735-9. Fed Regist. 2013. PMID: 23678676
-
Scheduling synthetic cathinone substances under the Controlled Substances Act.Psychopharmacology (Berl). 2019 Mar;236(3):845-860. doi: 10.1007/s00213-018-5129-8. Epub 2019 Apr 10. Psychopharmacology (Berl). 2019. PMID: 30969348 Review.
-
Bath salts and synthetic cathinones: an emerging designer drug phenomenon.Life Sci. 2014 Feb 27;97(1):2-8. doi: 10.1016/j.lfs.2013.07.023. Epub 2013 Aug 2. Life Sci. 2014. PMID: 23911668 Free PMC article. Review.
Cited by
-
In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Neuropsychopharmacology. 2013 Mar;38(4):563-73. doi: 10.1038/npp.2012.233. Epub 2012 Nov 8. Neuropsychopharmacology. 2013. PMID: 23212455 Free PMC article.
-
Are "bath salts" on your differential list? A case report of delirium and agitation after use of illicit bath salts.Prim Care Companion CNS Disord. 2013;15(2):PCC.12l01384. doi: 10.4088/PCC.12l01384. Prim Care Companion CNS Disord. 2013. PMID: 23930228 Free PMC article. No abstract available.
-
Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.Prim Care Companion CNS Disord. 2013;15(3):PCC.12f01459. doi: 10.4088/PCC.12f01459. Epub 2013 May 16. Prim Care Companion CNS Disord. 2013. PMID: 24171138 Free PMC article. No abstract available.
-
Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.J Med Toxicol. 2012 Sep;8(3):310-3. doi: 10.1007/s13181-012-0232-4. J Med Toxicol. 2012. PMID: 22528592 Free PMC article.
-
"Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.ACS Chem Neurosci. 2013 Dec 18;4(12):1524-9. doi: 10.1021/cn4001236. Epub 2013 Oct 31. ACS Chem Neurosci. 2013. PMID: 24116392 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials